U.S. Dural Sealants And Fibrin Glues Market (2025 - 2035) Size, Share & Trends Analysis Report By CPT Procedure Code (61510 / 61512, 61320 - 61323, 61518, 62140 / 62141, 63707, 63709, 63710), By End Use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Segment Definitions
                        1.2.1. CPT Procedure Codes
                        1.2.2. End Use
                        1.2.3. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in North America
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. CPT Procedure Codes
                        2.2.2. End Use outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Dural Sealants and Fibrin Glues Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Rising neurosurgical and spinal procedures
                            3.2.1.2. Focus on patient safety and reduced reoperations
                            3.2.1.3. Breakthrough biomaterials driving next-gen dural repair
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Unnecessary back surgeries limiting ethical utilization
                            3.2.2.2. Availability of alternative techniques
                    3.3. U.S. Dural Sealants and Fibrin Glues Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Bargaining power of suppliers
                            3.3.1.2. Bargaining power of buyers
                            3.3.1.3. Threat of substitutes
                            3.3.1.4. Threat of new entrants
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Economic landscape
                            3.3.2.3. Social landscape
                            3.3.2.4. Technological landscape
                            3.3.2.5. Environmental landscape
                            3.3.2.6. Legal landscape
Chapter 4. U.S. Dural Sealants and Fibrin Glues Market: CPT Procedure Codes Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. Dural Sealants and Fibrin Glues Market: CPT Procedure Codes Movement Analysis
                    4.3. U.S. Dural Sealants and Fibrin Glues Market by CPT Procedure Codes Outlook (USD Million)
                    4.4. Market Size & Forecasts and Trend Analyses, 2024 to 2035 for the following
                    4.5. 61510 / 61512 - Craniotomy for Supratentorial Lesion Removal
                        4.5.1. 61510 / 61512 - Craniotomy for Supratentorial Lesion Removal Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
                    4.6. 61320 - 61323 - Craniectomy or Craniotomy, Decompressive (With or Without Duraplasty)
                        4.6.1. 61320 - 61323 - Craniectomy or Craniotomy, Decompressive (With or Without Duraplasty) Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
                    4.7. 61518- Craniotomy for Infratentorial/Posterior Fossa Lesion
                        4.7.1. 61518- Craniotomy for Infratentorial/Posterior Fossa Lesion Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
                    4.8. 62140 / 62141- Cranioplasty or Dural Reconstruction
                        4.8.1. 62140 / 62141- Cranioplasty or Dural Reconstruction Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
                    4.9. 63707- Repair of CSF Leak, Cranial or Spinal, Without Laminectomy
                        4.9.1. 63707- Repair of CSF Leak, Cranial or Spinal, Without Laminectomy Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
                    4.10. 63709 - Repair of CSF Leak or Pseudomeningocele with Laminectomy
                        4.10.1. 63709 - Repair of CSF Leak or Pseudomeningocele with Laminectomy Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
                    4.11. 63710- Dural Graft (Spinal)
                        4.11.1. 63710- Dural Graft (Spinal) Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
                    4.12. 63030 - Laminotomy/Laminectomy (Lumbar), Decompression of Nerve Root
                        4.12.1. 63030 - Laminotomy/Laminectomy (Lumbar), Decompression of Nerve Root Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
                    4.13. 63047 - Laminectomy, >1 Vertebral Segment, Lumbar
                        4.13.1. 63047 - Laminectomy, >1 Vertebral Segment, Lumbar Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
                    4.14. 22612 / 22630 - Posterior Spinal Fusion with Decompression
                        4.14.1. 22612 / 22630 - Posterior Spinal Fusion with Decompression Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
Chapter 5. U.S. Dural Sealants and Fibrin Glues Market: End Use Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. Dural Sealants and Fibrin Glues Market: End Use Movement Analysis
                    5.3. U.S. Dural Sealants and Fibrin Glues Market by End Use Outlook (USD Million)
                    5.4. Market Size & Forecasts and Trend Analyses, 2024 to 2035 for the following
                    5.5. Hospitals
                        5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
                    5.6. Ambulatory Surgical Centers
                        5.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
                    5.7. Specialty Clinics
                        5.7.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
Chapter 6. Competitive Landscape
                    6.1. Market Participant Categorization
                    6.2. Key Company Profiles
                        6.2.1. Integra LifeSciences
                            6.2.1.1. Company overview
                            6.2.1.2. Financial performance
                            6.2.1.3. Product benchmarking
                            6.2.1.4. Strategic initiatives
                        6.2.2. Stryker
                            6.2.2.1. Company overview
                            6.2.2.2. Financial performance
                            6.2.2.3. Product benchmarking
                            6.2.2.4. Strategic initiatives
                        6.2.3. Baxter
                            6.2.3.1. Company overview
                            6.2.3.2. Financial performance
                            6.2.3.3. Product benchmarking
                            6.2.3.4. Strategic initiatives
                        6.2.4. Ethicon (J&J)
                            6.2.4.1. Company overview
                            6.2.4.2. Financial performance
                            6.2.4.3. Product benchmarking
                            6.2.4.4. Strategic initiatives
                        6.2.5. Takeda Pharmaceutical
                            6.2.5.1. Company overview
                            6.2.5.2. Financial performance
                            6.2.5.3. Product benchmarking
                            6.2.5.4. Strategic initiatives
                        6.2.6. B. Braun Medical
                            6.2.6.1. Company overview
                            6.2.6.2. Financial performance
                            6.2.6.3. Product benchmarking
                            6.2.6.4. Strategic initiatives
                        6.2.7. Cook Medical
                            6.2.7.1. Company overview
                            6.2.7.2. Financial performance
                            6.2.7.3. Product benchmarking
                            6.2.7.4. Strategic initiatives
                        6.2.8. Polyganics
                            6.2.8.1. Company overview
                            6.2.8.2. Financial performance
                            6.2.8.3. Product benchmarking
                            6.2.8.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. dural sealants and fibrin glues market, by CPT procedure codes, 2024 - 2035 (USD Million)
Table 4 U.S. dural sealants and fibrin glues market, by end use, 2024 - 2035 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. dural sealants and fibrin glues: market outlook
Fig. 9 U.S. dural sealants and fibrin glues market competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 U.S. dural sealants and fibrin glues market driver impact
Fig. 15 U.S. dural sealants and fibrin glues market restraint impact
Fig. 16 U.S. dural sealants and fibrin glues market strategic initiatives analysis
Fig. 17 U.S. dural sealants and fibrin glues market: CPT procedure codes movement analysis
Fig. 18 U.S. dural sealants and fibrin glues market: CPT procedure codes outlook and key takeaways
Fig. 19 61510 / 61512 - Craniotomy for supratentorial lesion removal market revenue estimates and forecasts, 2024 - 2035 (USD Million)
Fig. 20 61320 - 61323 - Craniectomy or craniotomy, decompressive (with or without duraplasty) market revenue estimates and forecasts, 2024 - 2035 (USD Million)
Fig. 21 61518- Craniotomy for infratentorial/posterior fossa lesion market revenue estimates and forecasts, 2024 - 2035 (USD Million)
Fig. 22 62140 / 62141- Cranioplasty or dural reconstruction market revenue estimates and forecasts, 2024 - 2035 (USD Million)
Fig. 23 63707- Repair of CSF leak, cranial or spinal, without laminectomy market revenue estimates and forecasts, 2024 - 2035 (USD Million)
Fig. 24 63709 - Repair of CSF leak or pseudomeningocele with laminectomy market revenue estimates and forecasts, 2024 - 2035 (USD Million)
Fig. 25 63710- Dural graft (spinal) market revenue estimates and forecasts, 2024 - 2035 (USD Million)
Fig. 26 63030 - Laminotomy/laminectomy (lumbar), decompression of nerve root market revenue estimates and forecasts, 2024 - 2035 (USD Million)
Fig. 27 63047 - Laminectomy, >1 vertebral segment, lumbar market revenue estimates and forecasts, 2024 - 2035 (USD Million)
Fig. 28 22612 / 22630 - Posterior spinal fusion with decompression market revenue estimates and forecasts, 2024 - 2035 (USD Million)
Fig. 29 U.S. dural sealants and fibrin glues market end use movement analysis
Fig. 30 U.S. dural sealants and fibrin glues market, end- use outlook key takeaways
Fig. 31 Hospitals market revenue estimates and forecasts, 2024 - 2035 (USD Million)
Fig. 32 Ambulatory surgical centers market revenue estimates and forecasts, 2024 - 2035 (USD Million)
Fig. 33 Specialty clinics market revenue estimates and forecasts, 2024 - 2035 (USD Million)
Fig. 34 Participant categorization- U.S. dural sealants and fibrin glues market
Fig. 35 Market share of key market players- U.S. dural sealants and fibrin glues market